🕵️ Lineage CELL Therapeutics, Inc. ($LCTX)

SEC insider & ownership activity, last 12 months · CIK 876343 · every row links its SEC filing

Over the last 12 months insiders bought $24K with no open-market selling against it. Brian M. Culley bought $24K in discretionary trades (Mar). Neal C. Bradsher trimmed 24.5% → 23.1%; Broadwood Partners, L.P. trimmed 24.3% → 23.0%. No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Mar 2026: net +$24K Mar 2026: net +$24K Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

1 buyer, $24K (1 lots) · 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Brian M. Culley1$24K 0Mar 12, 2026

5%+ holders

HolderStakeClassScheduleEvent
Neal C. Bradsher 23.1% 13DNov 12, 2025 filing ↗
Broadwood Partners, L.P. 23.0% 13DNov 12, 2025 filing ↗
Broadwood Capital, Inc. 23.0% 13DNov 12, 2025 filing ↗
Blackrock, Inc. 5.3% 13GJul 29, 2026 filing ↗
Chernett Jorey 5.0% 13GSep 26, 2025 filing ↗

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Don M Bailey$96KSep 24, 2025 filing ↗
Don M Bailey$97KSep 10, 2025 filing ↗

Material events (8-K)

ItemEvent date
Shareholder vote (5.07)Jun 9, 2026 filing ↗
Other events (8.01)Jun 9, 2026 filing ↗
Earnings (2.02)May 12, 2026 filing ↗
Financial Statements and Exhibits (9.01)May 12, 2026 filing ↗
Other events (8.01)Mar 11, 2026 filing ↗
Financial Statements and Exhibits (9.01)Mar 11, 2026 filing ↗
Earnings (2.02)Mar 5, 2026 filing ↗
Financial Statements and Exhibits (9.01)Mar 5, 2026 filing ↗
Other events (8.01)Nov 28, 2025 filing ↗
Other events (8.01)Nov 20, 2025 filing ↗
Other events (8.01)Nov 12, 2025 filing ↗
Earnings (2.02)Nov 6, 2025 filing ↗
Financial Statements and Exhibits (9.01)Nov 6, 2025 filing ↗
Reg FD disclosure (7.01)Aug 26, 2025 filing ↗
Other events (8.01)Aug 26, 2025 filing ↗
Financial Statements and Exhibits (9.01)Aug 26, 2025 filing ↗
Earnings (2.02)Aug 12, 2025 filing ↗
Financial Statements and Exhibits (9.01)Aug 12, 2025 filing ↗